Al-Saleem, E. v. Health Network Lab.

CourtSuperior Court of Pennsylvania
DecidedJanuary 3, 2023
Docket795 EDA 2022
StatusUnpublished

This text of Al-Saleem, E. v. Health Network Lab. (Al-Saleem, E. v. Health Network Lab.) is published on Counsel Stack Legal Research, covering Superior Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Al-Saleem, E. v. Health Network Lab., (Pa. Ct. App. 2023).

Opinion

J-A24020-22

NON-PRECEDENTIAL DECISION - SEE SUPERIOR COURT I.O.P. 65.37

ESSEL AL-SALEEM : IN THE SUPERIOR COURT OF : PENNSYLVANIA Appellant : : : v. : : : HEALTH NETWORK LABORATORIES, : No. 795 EDA 2022 L.P. :

Appeal from the Order Entered February 17, 2022 In the Court of Common Pleas of Lehigh County Civil Division at No(s): 2020-C-1255

BEFORE: PANELLA, P.J., BENDER, P.J.E., and SULLIVAN, J.

MEMORANDUM BY PANELLA, P.J.: FILED JANUARY 3, 2023

Essel Al-Saleem, M.D., appeals from the trial court’s February 17, 2022

order entering summary judgment in favor of Health Network Laboratories,

L.P. (“HNL”), and against Dr. Al-Saleem. Additionally, Dr. Al-Saleem

challenges the February 2, 2022 order sustaining in part and overruling in part

HNL’s preliminary objections and dismissing Count II of Dr. Al-Saleem’s

second amended complaint, which was made final by the entry of summary

judgment. After careful review, we affirm.

Dr. Al-Saleem is a board-certified pathologist with a specialty in

hematopathology. HNL operates anatomical pathology labs. Dr. Al-Saleem

and HNL executed an employment agreement whereby HNL employed Dr. Al-

Saleem to provide anatomical and clinical pathology services beginning on July

15, 2019, and concluding on December 31, 2021. The employment agreement J-A24020-22

permits HNL to terminate the agreement for cause without notice and without

further obligation to compensate Dr. Al-Saleem. The employment agreement

also allows HNL to terminate the agreement without cause, provided HNL

affords Dr. Al-Saleem 90 days’ written notice of termination. Termination

without cause entitles Dr. Al-Saleem to an additional three months’ salary.

HNL terminated Dr. Al-Saleem’s employment on December 2, 2019,

pursuant to the provision of the employment agreement governing

termination without cause. HNL instructed Dr. Al-Saleem to stop reporting to

work but continued to pay Dr. Al-Saleem’s salary through the 90-day notice

period. HNL also paid Dr. Al-Saleem an additional three months’ salary

following the conclusion of the notice period.

On May 28, 2020, Dr. Al-Saleem filed a complaint alleging wrongful

termination, violation of Pennsylvania’s Whistleblower Law,1 and breach of

contract. Dr. Al-Saleem alleged that she was terminated in retaliation for her

numerous reports about lab practices she believed were “unsafe, unethical,

illegal and/or out of compliance[.]” Complaint, 5/28/20, ¶ 31. Dr. Al-Saleem

raised concerns about, among others, “outdated” reporting values, which

resulted in unnecessary testing; lack of pathologist review before samples

were sent to the cytopathology section; and alterations made to her own

reports without her knowledge or approval. See id. at ¶¶ 36-39, 52-53. Dr.

____________________________________________

1 See 43 P.S. §§ 1421-1428.

-2- J-A24020-22

Al-Saleem alleged that she spoke with several superiors about these concerns.

See id. at ¶¶ 43-47, 49.

Dr. Al-Saleem subsequently filed an amended complaint.2 HNL filed

preliminary objections asserting the complaint failed to allege facts sufficient

to constitute a cause of action. Dr. Al-Saleem filed a response. Following oral

argument, the trial court sustained HNL’s preliminary objections and granted

Dr. Al-Saleem permission to file a second amended complaint.

On July 16, 2021, Dr. Al-Saleem filed her second amended complaint.

Therein, Dr. Al-Saleem alleged that the use of “outdated” limits for normal

interval values in tests caused unnecessary additional testing, and in turn, “in

unwarranted billing to insurance companies, and governmental payors

including, without limitation, Medicare and Medicaid.” Second Amended

Complaint, 7/16/21, at ¶ 37; see also id. at ¶¶ 39, 54. Further, Dr. Al-Saleem

alleged that such unnecessary testing “would fall within the company’s internal

definition of ‘abuse’ which includes practices that may directly or indirectly

result in unnecessary cost to the Medicare program or other federal or state

programs.” Id. at ¶ 55; see also id. (stating the same definition of “abuse”

is used in HNL’s compliance investigations policy). Dr. Al-Saleem also

generally alleged that HNL engaged in self-referral, which constitutes fraud.

See id. at ¶¶ 57-58.

2 HNL filed preliminary objections to the original complaint, but they were dismissed as moot after Dr. Al-Saleem filed the amended complaint.

-3- J-A24020-22

HNL again filed preliminary objections claiming the second amended

complaint had not remedied the defects of the first amended complaint. Dr.

Al-Saleem filed a response. The parties appeared for oral argument on the

preliminary objections in December 2021. On February 2, 2022, the trial court

entered an order sustaining in part and overruling in part HNL’s preliminary

objections and dismissing Count II (Whistleblower Law) of Dr. Al-Saleem’s

second amended complaint. In particular, the trial court concluded Dr. Al-

Saleem failed to allege she made a good faith report of waste or wrongdoing

by HNL. See Order, 2/2/22.

Prior to the final resolution of the preliminary objections, HNL also filed

a motion for summary judgment on all three counts.3 HNL argued that Dr. Al-

Saleem’s wrongful termination claim fails as a matter of law because she did

not establish that she was an at-will employee, where her position was

governed by an employment agreement. Additionally, HNL argued that Dr. Al-

Saleem failed to establish either that HNL breached the employment

agreement by barring her from working during the 90-day notice period or

that she suffered monetary damages as a result. Dr. Al-Saleem filed an

answer. The trial court conducted a hearing, and on February 17, 2022, the

court entered an order granting summary judgment in favor of HNL and

3Because the trial court dismissed Count II in its February 2, 2022 order, the court did not address the Whistleblower Law claim on summary judgment.

-4- J-A24020-22

against Dr. Al-Saleem on the remaining wrongful termination and breach of

contract claims. The instant timely appeal followed.

On appeal, Dr. Al-Saleem raises the following questions for our review:

1. Did the trial court err in sustaining HNL’s preliminary objections with respect to Dr. Al-Saleem’s claim under the Whistleblower Law in holding that the operative complaint did not allege a good faith report of wrongdoing or waste[,] where Dr. Al-Saleem sufficiently pled that she made a good faith report of wrongdoing and waste, that Dr. Al-Saleem’s report made clear how HNL was guilty of wrongdoing and provided information sufficient to identify the laws violated, and explained how HNL’s wrongful acts violated the cited statutes?

2. Did the trial court err in granting HNL’s motion for summary judgment with respect to Dr. Al-Saleem’s claim of wrongful termination in holding that Dr. Al-Saleem was not an at-will employee because she had a written contract of employment[,] where Dr. Al-Saleem presented sufficient evidence that she was an at-will employee, as Dr. Al-Saleem was terminated without cause prior to the expiration of the purported term, and thus she was entitled to the Pennsylvania common law exception to the at- will employment doctrine requiring that employees not be retaliated against for opposition to and refusal to engage in illegal activity in violation of Pennsylvania public policy?

3.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bombar v. West American Insurance Co.
932 A.2d 78 (Superior Court of Pennsylvania, 2007)
Weaver v. Harpster
975 A.2d 555 (Supreme Court of Pennsylvania, 2009)
McLaughlin v. Gastrointestinal Specialists, Inc.
750 A.2d 283 (Supreme Court of Pennsylvania, 2000)
Morley v. Gory
814 A.2d 762 (Superior Court of Pennsylvania, 2002)
DiBonaventura v. Consolidated Rail Corp.
539 A.2d 865 (Supreme Court of Pennsylvania, 1988)
Greco v. Myers Coach Lines, Inc.
199 A.3d 426 (Superior Court of Pennsylvania, 2018)
Commonwealth v. Holston
211 A.3d 1264 (Superior Court of Pennsylvania, 2019)
Grose v. Procter & Gamble Paper Products
866 A.2d 437 (Superior Court of Pennsylvania, 2005)
Hart v. Arnold
884 A.2d 316 (Superior Court of Pennsylvania, 2005)
Feingold v. Hendrzak
15 A.3d 937 (Superior Court of Pennsylvania, 2011)
Mikhail v. Pennsylvania Organization for Women in Early Recovery
63 A.3d 313 (Superior Court of Pennsylvania, 2013)
H & R Block Eastern Tax Services, Inc. v. Zarilla
69 A.3d 246 (Superior Court of Pennsylvania, 2013)
Deal, M. v. The Children's Hosp. of Philadelphia
2019 Pa. Super. 346 (Superior Court of Pennsylvania, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Al-Saleem, E. v. Health Network Lab., Counsel Stack Legal Research, https://law.counselstack.com/opinion/al-saleem-e-v-health-network-lab-pasuperct-2023.